When malignant pleural mesothelioma is suspected, physicians must confirm the diagnosis to prescribe the most effective treatment plan. Cytokeratin 5 and 5/6 are important proteins that help to distinguish malignant mesothelioma from pulmonary adenocarcinoma, the most common type of lung cancer. What Is Cytokeratin? Cytokeratin is a type of protein found on epithelial cells, which are the
Founded in 1887, The American Smelting and Refining Company (ASARCO) grew to encompass mining, smelting, and refining operations until it became a subsidiary of Grupo Mexico in 1999. In 2005, ASARCO filed for bankruptcy protection, and in 2009, the ASARCO Asbestos Personal Injury Settlement Trust was created to compensate asbestos victims. ASARCO History and Asbestos
Palliative care has long been known to offer significant benefits to patients suffering from malignant mesothelioma, as well as other advanced cancers. But to date, little has been known about the effectiveness of palliative care delivered virtually rather than in person. Now, a study conducted by Joseph A. Greer, PhD, of Massachusetts General Hospital and
Dr. Rafael Santana-Davila is a medical oncologist who specializes in treating patients with thoracic cancers, including lung cancer and pleural mesothelioma. He practices at the Providence Swedish Cancer Center in Seattle, Washington. Asked about his practice philosophy, Dr. Santana-Davila says, “My patients teach me life lessons that make me a better person.” His interests include
Dr. Juskaran S. Chadha is a medical oncologist and Assistant Professor at the University of South Florida, Morsani College of Medicine. He is the Medical Director of Moffitt Cancer Center at Wesley Chapel. Dr. Chadha’s clinical focus is solid tumor oncology, with special interests in genitourinary tract tumors, including prostate cancer, bladder cancer, kidney cancer,
Dr. Mark Onaitis is a thoracic surgeon who specializes in malignant and benign conditions of the chest, including lung cancer, esophageal cancer, thymic malignancies, and pleural mesothelioma. He practices at the University of California, San Diego. Dr. Onaitis uses minimally invasive approaches, including thoracoscopy and robotics, in his delivery of care. His clinical expertise lies
Dr. Gasparri is a thoracic surgeon and cardiothoracic surgeon at the Medical College of Wisconsin and Froedtert Hospital Cancer Center in Milwaukee, Wisconsin. He treats patients diagnosed with thoracic malignancies and benign diseases of all kinds, including lung cancer, mediastinal tumors, thymoma, and pleural mesothelioma. Education and Career Dr. Gasparri attended Marquette University as an
Dr. Christina Brzezniak is a medical oncologist who is board-certified in medical oncology, hematology, and internal medicine. She practices in the Reston, Virginia, office of Virginia Cancer Specialists, where she manages malignancies of all types, with a special interest in the use of immunotherapy for the treatment of pleural mesothelioma and lung cancer. Education and
Dr. Matt Ballo is a radiation oncologist and the Vice Chair for Regional Oncology at the Cleveland Clinic. His patient care includes the use of innovative radiation therapy tools for the treatment of both thoracic and abdominal cancers, including malignant pleural and peritoneal mesothelioma and lung cancer. He is recognized for his expertise in head
Dr. Thomas J. Miner is a surgical oncologist and the Chief of Surgical Oncology at Rhode Island Hospital in Providence, Rhode Island. He is also a Professor of Surgery and Chief of Surgical Oncology at the Warren Alpert School of Medicine at Brown University, as well as the Associate Surgical Residency Program Director there. Education